October: Episode 4 Watch time: 20 min
BAD 2020 virtual congress highlights
The fourth episode focuses on the latest updates and hot topics relating to SKYRIZI (risankizumab) and biologic treatment for moderate to severe psoriasis – presented at the 100th British Association of Dermatologists annual meeting – held virtually this year.
- SKYRIZI (risankizumab) Summary of Product Characteristics.
- Smith CH, et al. BJD 2020, Published: March 18, 2020. DOI:10.1111/bjd.19039.
- BAD 2020 guideline update: NMA bjd19039-sup-0002-FileS2.docx (Accessed August 2020).
UK-RISN-210516 Date of Preparation: October 2021